Because the immune response may be suppressed in the TME of EGFR-mutated NSCLC, as suggested by previous studies (9, 10), we investigated the sensitivity of EGFR WT and EGFR-mutated cells to T cell–mediated killing in an antigen-specific manner. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.